Cargando…
Immune Thrombocytopenia: Recent Advances in Pathogenesis and Treatments
Immune thrombocytopenia (ITP) is a rare autoimmune disease due to both a peripheral destruction of platelets and an inappropriate bone marrow production. Although the primary triggering factors of ITP remain unknown, a loss of immune tolerance—mostly represented by a regulatory T-cell defect—allows...
Autores principales: | Audia, Sylvain, Mahévas, Matthieu, Nivet, Martin, Ouandji, Sethi, Ciudad, Marion, Bonnotte, Bernard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8171374/ https://www.ncbi.nlm.nih.gov/pubmed/34095758 http://dx.doi.org/10.1097/HS9.0000000000000574 |
Ejemplares similares
-
Emerging Therapies in Immune Thrombocytopenia
por: Audia, Sylvain, et al.
Publicado: (2021) -
Antiplatelet Antibodies Do Not Predict the Response to Intravenous Immunoglobulins during Immune Thrombocytopenia
por: Rogier, Thomas, et al.
Publicado: (2020) -
Efficiency of human monocyte-derived suppressor cell-based treatment in graft-versus-host disease prevention while preserving graft-versus-leukemia effect
por: Janikashvili, Nona, et al.
Publicado: (2021) -
Efficacy and safety of dapsone as second line therapy for adult immune thrombocytopenia: A retrospective study of 42 patients
por: Estève, Clémentine, et al.
Publicado: (2017) -
Human Monocyte-Derived Suppressor Cell Supernatant Induces Immunoregulatory Effects and Mitigates xenoGvHD
por: Gérard, Claire, et al.
Publicado: (2022)